BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 17215448)

  • 41. Tissue-type plasminogen activator is involved in the process of neuronal death induced by oxygen-glucose deprivation in culture.
    Nagai N; Yamamoto S; Tsuboi T; Ihara H; Urano T; Takada Y; Terakawa S; Takada A
    J Cereb Blood Flow Metab; 2001 Jun; 21(6):631-4. PubMed ID: 11488532
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disruption of tissue plasminogen activator gene reduces macrophage migration.
    Ling C; Zou T; Hsiao Y; Tao X; Chen ZL; Strickland S; Song H
    Biochem Biophys Res Commun; 2006 Oct; 349(3):906-12. PubMed ID: 16978586
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of fluvastatin and valsartan, alone and in combination, on postprandial vascular inflammation and fibrinolytic activity in patients with essential hypertension.
    Liu L; Zhao SP; Zhou HN; Li QZ; Li JX
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):50-5. PubMed ID: 17666915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic architecture of tissue-type plasminogen activator and plasminogen activator inhibitor-1.
    Asselbergs FW; Pattin K; Snieder H; Hillege HL; van Gilst WH; Moore JH
    Semin Thromb Hemost; 2008 Sep; 34(6):562-8. PubMed ID: 19085655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasminogen Activator Inhibitor-1 Reduces Tissue-Type Plasminogen Activator-Dependent Fibrinolysis and Intrahepatic Hemorrhage in Experimental Acetaminophen Overdose.
    Pant A; Kopec AK; Baker KS; Cline-Fedewa H; Lawrence DA; Luyendyk JP
    Am J Pathol; 2018 May; 188(5):1204-1212. PubMed ID: 29454747
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Glucagon as a determinant of fibrinolytic activity in men with different stages of glucose tolerance: impact of glucagon on fibrinolysis.
    Henkel E; Gallo S; Siegert G; Koehler C; Hanefeld M
    Blood Coagul Fibrinolysis; 2007 Jun; 18(4):327-34. PubMed ID: 17473573
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Binding of tissue plasminogen activator to vascular grafts.
    Harvey RA; Kim HC; Pincus J; Trooskin SZ; Wilcox JN; Greco RS
    Thromb Haemost; 1989 Feb; 61(1):131-6. PubMed ID: 2501890
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Decreased peritoneal tissue plasminogen activator during prolonged laparoscopic surgery.
    Brokelman WJ; Holmdahl L; Janssen IM; Falk P; Bergström M; Klinkenbijl JH; Reijnen MM
    J Surg Res; 2009 Jan; 151(1):89-93. PubMed ID: 18541262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A reconstituted dilute blood clot lysis assay for the medium throughput screening of thrombolytic compounds.
    Gadbut AP; Schullek JR; Hanel AM; MacAllan DR
    Anal Biochem; 1999 May; 270(1):24-32. PubMed ID: 10328761
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Delayed treatment with plasminogen activator inhibitor-1 decoys reduces tubulointerstitial fibrosis.
    Gonzalez J; Klein J; Chauhan SD; Neau E; Calise D; Nevoit C; Chaaya R; Miravete M; Delage C; Bascands JL; Schanstra JP; Buffin-Meyer B
    Exp Biol Med (Maywood); 2009 Dec; 234(12):1511-8. PubMed ID: 19934371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interactions of fibrinolytic system proteins with lysine-containing surfaces.
    McClung WG; Clapper DL; Anderson AB; Babcock DE; Brash JL
    J Biomed Mater Res A; 2003 Sep; 66(4):795-801. PubMed ID: 12926031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator.
    Danielyan K; Ganguly K; Ding BS; Atochin D; Zaitsev S; Murciano JC; Huang PL; Kasner SE; Cines DB; Muzykantov VR
    Circulation; 2008 Sep; 118(14):1442-9. PubMed ID: 18794394
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Corn trypsin inhibitor decreases tissue-type plasminogen activator-mediated fibrinolysis of human plasma.
    Nielsen VG
    Blood Coagul Fibrinolysis; 2009 Apr; 20(3):191-6. PubMed ID: 19657316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent.
    Yepes M; Sandkvist M; Coleman TA; Moore E; Wu JY; Mitola D; Bugge TH; Lawrence DA
    J Clin Invest; 2002 Jun; 109(12):1571-8. PubMed ID: 12070304
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clot lysis: role of plasminogen activator inhibitors in haemostasis and therapy.
    Pawse AR; Tarachand U
    Indian J Exp Biol; 1997 Jun; 35(6):545-52. PubMed ID: 9357156
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Upregulation of tPA/plasminogen proteolytic system in the periphery of amyloid deposits in the Tg2576 mouse model of Alzheimer's disease.
    Lee JY; Kweon HS; Cho E; Lee JY; Byun HR; Kim DH; Kim YH; Han PL; Koh JY
    Neurosci Lett; 2007 Aug; 423(1):82-7. PubMed ID: 17662525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An evaluation of normal saline and taurolidine on intra-abdominal adhesion formation and peritoneal fibrinolysis.
    Tarhan OR; Barut I; Sezik M
    J Surg Res; 2008 Jan; 144(1):151-7. PubMed ID: 17981298
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hyperfibrinolysis in alcoholic cirrhosis: relative plasminogen activator inhibitor type 1 deficiency.
    Ferguson JW; Helmy A; Ludlam C; Webb DJ; Hayes PC; Newby DC
    Thromb Res; 2008; 121(5):675-80. PubMed ID: 17870147
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice.
    Nagai N; De Mol M; Lijnen HR; Carmeliet P; Collen D
    Circulation; 1999 May; 99(18):2440-4. PubMed ID: 10318667
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Direct effects of alcohol on hepatic fibrinolytic balance: implications for alcoholic liver disease.
    Seth D; Hogg PJ; Gorrell MD; McCaughan GW; Haber PS
    J Hepatol; 2008 Apr; 48(4):614-27. PubMed ID: 18289715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.